MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Bausch Health Companies Stock

Bausch Health Companies Inc.

BHC.TOTSXMarkt
CA$8.92
-0.7% today

Company data

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Canada
CEO
Thomas J. Appio
Employees
20,300
Market cap
$3.3 B
IPO
03/04/1996

Bausch Health Companies Inc. is a global healthcare enterprise dedicated to the creation, production, and sale of a diverse array of pharmaceutical, medical device, and over-the-counter items. Headquartered in Laval, Canada, the company is led by CEO Thomas J. Appio. The operations are strategically organized into…

Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.

Bausch Health Companies stock: price history

16/10/25+5.4 %16/10/26

1D

-0.7%

1W

+3.2%

1M

+11.8%

6M

+10.3%

YTD

-6.4%

1Y

+5.4%

2Y

-23.5%

5Y

-74.7%

10Y

-69.2%

Next earnings date

Next earnings date

28/10/2026 (in 11 days)

Volatility around earnings

~68% stronger price swings than usual

Pattern chart

Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 15/10/26. Not a buy or sell signal.Beta

What does this mean?

Double bottom

Bullish

The price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.

Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.

Ask the agents about Bausch Health Companies

Analyst assessment of Bausch Health Companies

0

STRONG BUY

7

BUY

11

HOLD

2

SELL

0

STRONG SELL

20

TOTAL · Hold

As of: 27/04/2026

ANALYST FIRMRATINGACTIONDATE
RBC CapitalSector Performmaintain27/04/2026
BarclaysEqual Weightmaintain25/02/2026
Truist SecuritiesHoldmaintain07/01/2026
RBC CapitalSector Performmaintain02/05/2025 (older than 12 months)
JefferiesBuy → Holddowngrade06/02/2025 (older than 12 months)
RBC CapitalSector Performmaintain30/01/2025 (older than 12 months)
RBC CapitalSector Performmaintain01/11/2024 (older than 12 months)
Piper SandlerNeutral → Underweightdowngrade02/08/2024 (older than 12 months)

Bausch Health Companies stock metrics

P/E

-2.14

P/B

-1.33

EV/EBITDA

10.41

RETURN ON EQUITY

-14.2%

NET MARGIN

9.0%

DEBT/EQUITY

-11.73

DIVIDEND YIELD

0.0%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

88.6%

FLOAT SHARES

331,339,189

AVG. DAILY VOLUME (30D)

508,097

Dividends & Stock splits

Dividends

EX-DATEPAY DATEAMOUNTYIELD
10/11/201022/12/2010CA$1.005 %
30/08/201004/10/2010CA$0.101.6 %
31/05/201005/07/2010CA$0.102.5 %
04/03/201005/04/2010CA$0.102.5 %
30/11/200904/01/2010CA$0.105.1 %
Page 1 / 5

Stock splits

DATERATIO
05/10/20002:1
10/01/20002:1

Comparable stocks

Frequently asked questions about Bausch Health Companies stock

What does Bausch Health Companies do?

Bausch Health Companies Inc. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Canada.

The CEO is Thomas J. Appio, the company employs around 20,300 people.

The IPO was on 03/04/1996; the stock trades on TSX under the ticker BHC.TO.

What do analysts say about Bausch Health Companies stock?

20 analysts rate the stock, the consensus is Hold (as of 27/04/2026).

This is an external assessment, not a statement by Market Jury.

When does Bausch Health Companies report next?

The next earnings date is 28/10/2026.

Around past earnings, price swings were roughly 68% stronger than usual.

Does Bausch Health Companies pay a dividend?

Yes. The last dividend was CA$1.00 per share, ex-date 10/11/2010, paid on 22/12/2010.

The dividend yield is 0.0% (as of 30/06/2026).

Which stocks are comparable to Bausch Health Companies?

Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.

How can I get Bausch Health Companies stock analyzed?

Clicking "Analyze stock" lets five strategies assess Bausch Health Companies against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.